Embla Medical hf (FRA:5IQ) Other Current Receivables: €0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5IQ Embla Medical hf FRA:5IQ
71 GF Score
Price €3.51
GF Value €4.38
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Embla Medical hf Other Current Receivables?

Embla Medical hf FRA:5IQ 71 Other Current Receivables is €0.0 Mil as of Jun. 2026. GuruFocus rates FRA:5IQ with a GF Score™ of 71/100 and a GF Value™ of €4.38 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Embla Medical hf's Other Current Receivables for the quarter that ended in Jun. 2026 was €0.0 Mil.

Embla Medical hf Other Current Receivables Related Terms

Embla Medical hf Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Embla Medical hf's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf Other Current Receivables Chart

Embla Medical hf Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Embla Medical hf Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:5IQ
71GF Score
Embla Medical hf FRA:5IQ
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embla Medical hf Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.0 Mil mean?
Embla Medical hf (FRA:5IQ) has a Other Current Receivables of €0.0 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Embla Medical hf and its competitors.
Is Embla Medical hf's Other Current Receivables too high?
Embla Medical hf's current Other Current Receivables is €0.0 Mil. Overall, Embla Medical hf has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Other Current Receivables compare to ABT and SYK?
Embla Medical hf's Other Current Receivables of €0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Embla Medical hf and its competitors. Embla Medical hf's current Other Current Receivables is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Based on GuruFocus' analysis, Embla Medical hf (FRA:5IQ) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.38, compared to a current price of €3.51 — trading 20% below its estimated fair value. The current Other Current Receivables is €0.0 Mil. Embla Medical hf's overall GF Score™ is 71/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Embla Medical hf (FRA:5IQ), the current Other Current Receivables is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embla Medical hf (FRA:5IQ) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of €3.51 is trading 20% below its estimated GF Value™ of €4.38. GuruFocus considers Embla Medical hf to be Modestly Undervalued.

Key valuation signals for FRA:5IQ:

  • Other Current Receivables: €0.0 Mil
  • GF Value™: €4.38 vs. price of €3.51 (20% below fair value)
  • GF Score™: 71/100 with 1 warning sign

No single metric tells the full story. See the FRA:5IQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Embla Medical hf Business Description

Other Exchanges 0FIW:UKEMBLA:Denmark
Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
71GF Score

Get the complete analysis for FRA:5IQ

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.51
Price
€4.38
GF Value